Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10505 publications
Bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in advanced HIV disease.
Journal: Medicina
Published: October 18, 2025
The efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in treatment-naïve and treatment-experienced patients with HIV.
Journal: Annals of medicine
Published: October 11, 2025
Understanding Degradation in Single-Crystalline Ni-Rich Li-Ion Battery Cathodes.
Journal: Chemical reviews
Published: October 09, 2025
Assessment of Mortality Rates Associated With Perioperative Deep Vein Thrombosis Screening and Prophylaxis in Cosmetic Outpatient Procedures: An Updated National Evaluation Using QUAD A Patient Safety Data.
Journal: Aesthetic surgery journal. Open forum
Published: October 06, 2025
Operando fluorescence lifetime imaging microscopy during Li+ intercalation into graphitic electrodes.
Journal: Chemical communications (Cambridge, England)
Published: October 04, 2025
Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.
Journal: International journal of STD & AIDS
Published: October 03, 2025
Monitoring HIV Antiretroviral Therapy via Aptamer-Based Measurements in Preclinical Animal Models, in Human Plasma.
Journal: Advanced sensor research
Published: October 01, 2025
In vitro modulation of adipocyte differentiation by tenofovir alafenamide/disoproxil fumarate following challenge with recent ARV drugs.
Journal: Cell cycle (Georgetown, Tex.)
Published: September 30, 2025
Letters on "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: September 30, 2025
Month 12 outcomes of switching to long-acting cabotegravir + rilpivirine with an oral lead-in versus continuing bictegravir/ emtricitabine/tenofovir alafenamide in the Phase 3b randomized SOLAR study.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: September 30, 2025
Tenofovir Alafenamide and Body Weight: Have We Finally Tipped the Scale?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 23, 2025
Last Updated: 10/31/2025